Jonathan Yoken MD

Doctor Details
Retinal Disease / Vitreoretinal Surgery
Board Certified, American Board of Ophthalmology


Dr. Yoken graduated from Washington University in St. Louis with a B.A. degree in Biology. He subsequently attended St. Louis University School of Medicine and graduated Magna Cum Laude with a Distinction in Medical Research award. He was also elected to the Alpha Omega Alpha medical student honor society. After earning his medical degree, Dr. Yoken completed his internship at The University of Pennsylvania's Presbyterian Medical Center. He then went on to complete his ophthalmology residency at The University of Pennsylvania's Scheie Eye Institute, where he also served as chief resident. Dr. Yoken then served as a fellow in vitreoretinal surgery at Oregon Health Science University's Casey Eye Institute. During fellowship, he was awarded a Heed Ophthalmic Foundation Fellowship for research as well as a Distinguished Service Award.

After completing his fellowship, Dr. Yoken spent three years in private practice at the Retina Group of Florida, in Fort Lauderdale, where he served as an investigator in many landmark clinical trials of new treatments for macular degeneration, diabetic retinopathy and retinal vascular occlusions.

Dr. Yoken has broad experience in all areas of medical and surgical retinal disease, but he has a particular interest in macular degeneration. His research has been published in numerous journals, including Ophthalmology, Retina, Archives of Ophthalmology, Ophthalmic Surgery and Lasers and Investigative Ophthalmology and Visual Science. He has also authored a chapter on the treatment of macular degeneration. Dr. Yoken has presented his work at many local and national meetings. He is Board Certified and an active member of the American Academy of Ophthalmology, The Association for Research in Vision and Ophthalmology, The American Society of Retinal Specialists and the Oregon Academy of Ophthalmology.
Dr. Yoken's Patient Handouts:
Central Serous Retinopathy
Cystoid Macular Edema
Diabetic Retinopathy
Endophthalmitis
Eye Drop Schedule
Flashes And Floaters
Fluorescein And Indocyanine Green
Headache And Ocular Migraine
Macular Degeneration
Macular Hole
Macular Pucker
Monitoring For Plaquinil
Photodyamic Laser Treatment
Retained Lens Material After Cataract Surgery
Retinal Artery Or Vein Occlusion
Retinal Tears And Detachment
The Greatest Compliment We Can Receive
Uveitis
Vitamin and Mineral Supplementation
What Is The Retina

         
DR. YOKEN'S EDUCATION:

BORN:     August 30, 1971
Boston, MA
BUSINESS ADDRESS:    
EyeHealth Northwest
1306 Division St.
Oregon City, OR 97045
(503) 656-4221 (Phone)
(503) 656-4249 (Fax)
Eye Health Northwest
10819 SE Stark St., Suite 200
Portland, OR 97216
(503) 255-2291 (Phone)
(503) 252-1797 (Fax)

Eye Health Northwest
19558 NW Northrup
Portland, OR 97209
(503) 227-2020 (Phone)
(503) 222-0614 (Fax)

EDUCATION
Undergraduate:     Washington University
St. Louis, MO
August 1989 – May 1993, BA
Medical School:     St. Louis University School of Medicine
St. Louis, MO
August 1993 - May 1997, MD
Honors:     Graduated Magna cum Laude
Alpha Omega Alpha
M.D. with Distinction in Research Award
Peters Summer Fellowship for Research 1994
Internship:     Presbyterian Medical Center, University of Pennsylvania Health System Philadelphia, PA
June 1997 - June 1998, Transitional Internship
Residency:     Scheie Eye Institute, University of Pennsylvania
Philadelphia, PA
June 1998 - June 2001, Ophthalmology Residency
Honors:     Co-Chief Resident 2000 - 2001
Heed Ophthalmic Fellowship Award Recipient
National Eye Institute Travel Fellowship Award, ARVO 2000
Fellowship:     Casey Eye Institute, Oregon Health Sciences University Portland, OR
July 2001 - June 2003, Fellow in Vitreoretinal Disease and Surgery
Honors: Casey Eye Institute Distinguished Service Award, 2002
LICENSURE:    Oregon MD22939
CERTIFICATION:     National Board of Medical Examiners, 1997
American Board of Ophthalmology, November 2002
HOSPITAL AFFILIATIONS:     Legacy Good Samaritan Hospital, Portland, OR
Providence St. Vincent Medical Center, Portland, OR
Casey Eye Institute, Portland, OR
Adventist Medical Center, Portland, OR
PROFESSIONAL EXPERIENCE:     Private Practice, EyeHealth Northwest
June 1 2006 - Present
Retina Group of Florida
5601 N. Dixie Hwy.
Ft. Lauderdale, FL 33334
August 2003 - May 2006

ACADEMIC APPOINTMENTS:    
Associate Professor of Ophthalmology
Casey Eye Institute
July 2006 - Present
PROFESSIONAL ORGANIZATIONS:     American Medical Association
American Academy of Ophthalmology
Association for Research in Vision and Ophthalmology
Alpha Omega Alpha
PUBLICATIONS
Book Chapters:    Yoken J, Duncan JL, Berger JW, Duneaif J, Fine SL. Laser Photocoagulation for Choroidal Neovascularization in Age-related Macular Degeneration. In: Lim, J ed. Age-Related Macular Degeneration. New York, Marcel Dekker, Inc. 2002. pp. 181-201
Papers:     Lauer AK, Yoken J, Klein ML, Wilson DJ. Clinicopathologic Correlation of Successfully Treated Choroidal Neovascularization Lying Within the Notch of a Large Serous Retinal Pigment Epithelial Detachment. Arch Ophthalmol. 2004;122:1383-1390.
Murthy RC *, McFarland TJ *, Yoken J, Chen S, Barone C, Burke D, Zhang Y, Appukuttan B, and Stout JT. Corneal Transduction to Inhibit Angiogenesis and Graft Failure. Invest Ophthalmol Vis Sci.2003;44:1837-1842.

Yoken J, Forbes BJ, Maguire AM, Prenner JL, Carpentieri D. Microsporidial Endophthalmitis in a Patient With Acute Myelogenous Leukemia. Retina 2002; February 22(1):123-5.

Berger JW, Yoken J. Computer-assisted Quantitation of Choroidal Neovascularization for Clinical Trials. Invest Ophthalmol Vis Sci.2000; 41: 2286-2295.

Ho AC, Maguire MG, Yoken J, Lee MS, Shin DS, Javornik NB, Fine SL, the Choroidal Neovascularization Prevention Trial Research Group. Laser-induced Drusen Reduction Improves Visual Function at 1 Year. Ophthalmology 1999; 106: 1367-1374.

Piccone MR, Piltz JR, Yoken J. A false-positive Seidel test after Ahmed valve insertion. Ophthalmic Surgery and Lasers 1999; April 30(4): 313-314.

PUBLICATIONS Cont.
Papers Cont.:    Yoken J, Rantis PC, Vernava AM, Longo WE. Strategies for the Management of Colorectal Cancer Risk in Patients with Ulcerative Colitis. Surgical Research Communications 1997; 19, 37-43.
Abstracts:    Yoken J, Murthy R, McFarland T, Barone CM, Chen SL, Appukuttan B, Stout JT. Production of a Lentiviral Vector Containing an Endostatin:Kringle-5 Fusion Gene an Inhibitor of Post-Penetrating Keratoplasty Neovascularization in a Rabbit Model. [Arvo Abstract, Paper Presentation], Invest Ophthalmol Vis Sci, 2002; 43(4): S1868.
Yoken J, Sharma, A, Berger JW. Computer-assisted Quantitation of Choroidal Neovascularization for Clinical Trials. [ARVO abstract]. Invest Ophthalmol Vis Sci. 2000; 41(4): S162.

Yoken J, Piccone MR. Prevalence and Legal Implications of the Distribution of Videotapes to Patients undergoing Ophthalmic Surgical Procedures [ARVO abstract]. Invest Ophthalmol Vis Sci. 1999; 40(4): S286.

Berger JW, Shin DS, Sharma MC, Javornik NB, Lee MS, Yoken J, Ho AC, CNVPT Study Group. Comparison of manual and computer assisted drusen quantitation in a clinical trial [Academy Abstract]. 103rd AAO Final Program 1999; 197. Scientific paper nr 323.

LECTURES/PRESENTATIONS:    
Age Related Macular Degeneration: Current Perspectives. Broward County Ophthalmologic Society, September 13, 2004.
Gene Therapy in Age Related Macular Degeneration. Florida State Ophthalmological Society Annual Meeting, Sarasota, September 12, 2003.

Endoscopic Vitreoretinal Surgery. Grand Rounds, Casey Eye Institute and Devers Eye Institute, February 21, 2003

Vein Occlusion: Pathophysiology, Approach to Management, and New Therapeutic Modalities. Columbia River Gorge Vitreoretinal Update, July 19, 2002

The Management of Dislocated Intraocular Lenses Presented at “Thorny Issues in Ophthalmology”, COT continuing education course, Devers Eye Institute, June 10, 2002

Production of a Lentiviral Vector Containing an Endostatin:Kringle-5 Fusion Gene an Inhibitor of Post-Penetrating Keratoplasty Neovascularization in a Rabbit Model. Paper presentation, ARVO 2002

Computer-assisted Quantitation of Choroidal Neovascularization for Clinical Trials. Presented at the 126th Annual Scheie Eye Institute Alumni Meeting, May 2000
Doctor Ratings
Accurate Diagnosis
No Ratings
Courteous Staff
No Ratings
Ease of Appointment
No Ratings
Spends Time with Me
No Ratings
Would Recommend to Others?
No Ratings
Doctor Details
Board Certified
Yes
Primary Specialty
Retina
Title
Ophthalmologist (MD)